Business
AbCellera to Report Full Year 2021 Financial Results on February 24, 2022
VANCOUVER, British Columbia--(BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) announced today that it will report full year 2021 financial results after market
About this update from Abcellera Biologics Inc.
[{"type":"text","content":" VANCOUVER, British Columbia--(BUSINESS WIRE)--\nAbCellera (Nasdaq: ABCL) announced today that it will report full year 2021 financial results after market close on Thursday, February 24, 2022 and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day.\n\nThe live webcast of the earnings conference will be available through a link that will be posted on AbCellera’s Investor Relations website. A replay of the webcast will be available through the same link following the conference call.\n\nAbout AbCellera Biologics Inc.\n\nAbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development. To learn more, visit www.abcellera.com.\n\nSource: AbCellera Biologics Inc.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20220126005945/en/\n\nMedia: Jessica Yingling, Ph.D.; [email protected], +1(236)521-6774\nInvestor Relations: Melanie Solomon; [email protected], +1(778)729-9116\n\nSource: AbCellera","length":3025,"tagName":"div"}]